Clinical Trial Update: A Study Comparing the Efficacy of Intravenous Followed by Oral Itraconazole With Intravenous Caspofungin For Empiric Antifungal Therapy in Neutropenic Participants With Hematological Malignancy [Phase 4]

View source ↗

Summary

Phase 4 trial comparing intravenous followed by oral itraconazole versus intravenous caspofungin for empiric antifungal therapy in neutropenic patients with hem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Neoplasms

Drugs mentioned

• Caspofungin (caspofungin)
• Itraconazole (Itraconazole)

Snippet

Sponsor: Xian-Janssen Pharmaceutical Ltd. | Conditions: Hematologic Neoplasms | Phase 4 | Status: TERMINATED